Composition: Human Recombinant Coagulation Factor VIII 500IU Indication: Nuwiq contains the active substance human recombinant coagulation factor VIII (simoctocog alfa). Factor VIII is necessary for the blood to form clots and stop bleeding. In patients with hemophilia A (inborn factor VIII deficiency), factor VIII is missing or not working properly. Nuwiq replaces the missing factor Vlll and is used for treatment and prevention of bleeding in patients with hemophilia A and can be used for all age groups
Composition: Human immunoglobulin 10% (5g in 50ml)
Indication: Replacement therapy in primary immunodeficiency syndromes, Myeloma or chronic lymphatic leukemia with severe secondary hypogammaglobulinemia and recurrent infections and children with congenital AIDS and recurrent bacterial infections. Also has Immunomodulatory effect in Idiopathic thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgery to correct the platelet count, Guillain Barré syndrome, Kawasaki disease, Allogeneic bone marrow transplantation.
Composition: Human immunoglobulin 10g in 200ml
Indication: Replacement therapy in primary immunodeficiency syndromes, Myeloma or chronic lymphatic leukemia with severe secondary hypogammaglobulinemia and recurrent infections and children with congenital AIDS and recurrent bacterial infections. Also has Immunomodulatory effect in Idiopathic thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgery to correct the platelet count, Guillain Barré syndrome, Kawasaki disease, Allogeneic bone marrow transplantation.
Composition: Human immunoglobulin 2.5g in 50ml
Indication: Replacement therapy in primary immunodeficiency syndromes, Myeloma or chronic lymphatic leukemia with severe secondary hypogammaglobulinemia and recurrent infections and children with congenital AIDS and recurrent bacterial infections. Also has Immunomodulatory effect in Idiopathic thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgery to correct the platelet count, Guillain Barré syndrome, Kawasaki disease, Allogeneic bone marrow transplantation.
Composition: Human immunoglobulin 5% (5g in 100ml) Indication: Replacement therapy in primary immunodeficiency syndromes, Myeloma or chronic lymphatic leukemia with severe secondary hypogammaglobulinemia and recurrent infections and children with congenital AIDS and recurrent bacterial infections. Also has Immunomodulatory effect in Idiopathic thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgery to correct the platelet count, Guillain Barré syndrome, Kawasaki disease, Allogeneic bone marrow transplantation.
Composition: Human coagulation factor VIII 1000IU
Indication: Treatment and prevention of bleeding episodes in patients with hemophilia A (congenital or acquired FVIII deficiency), including previously treated patients (PTPs), previously untreated patients (PUPs) and patients undergoing major and minor surgical procedures; and for the treatment of inhibitors by Immune Tolerance Induction (ITI).
Composition: Human coagulation factor VIII 250IU
Indication: Treatment and prevention of bleeding episodes in patients with hemophilia A (congenital or acquired FVIII deficiency), including previously treated patients (PTPs), previously untreated patients (PUPs) and patients undergoing major and minor surgical procedures; and for the treatment of inhibitors by Immune Tolerance Induction (ITI).
Composition: Human coagulation factor VIII 500IU Indication: Treatment and prevention of bleeding episodes in patients with hemophilia A (congenital or acquired FVIII deficiency), including previously treated patients (PTPs), previously untreated patients (PUPs) and patients undergoing major and minor surgical procedures; and for the treatment of inhibitors by Immune Tolerance Induction (ITI).
Composition: Human Coagulation Factor IX 500IU Indication: Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency).
Composition: Human prothrombin complex concentrate containing Factors II, VII, IX, X, as well as the inhibitor, protein C, and its cofactor protein S. Indication: Octaplex is used to treat and prevent bleeding caused by medicines called vitamin K antagonists (such as warfarin). Octaplex is used when rapid correction of the shortage is required in people born with a shortage of the vitamin K dependent clotting factors II and X. It is used when purified specific clotting factor product is not available.
Composition: Ondansetron 8mg
Indication: Ondansetron is indicated for the control of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. Likewise, it is indicated for the prevention and treatment of postoperative nausea and vomiting.
Composition: Water; glucose monohydrate; sodium citrate; sodium chloride; potassium chloride Indication: ORS for the dietary management of body dehydration, especially during diarrhea, vomiting, and in situations associated with a risk of dehydration.
Composition: Glucose monohydrate, Sodium citrate, Sodium chloride, Potassium chloride. Indication: Orsalit with raspberry flavour is a food for special medical purposes for the dietary management of body dehydration, especially during diarrhoea or vomiting, and in situations associated with a risk of dehydration. Orsalit with raspberry flavour supplements body fluids and mineral substances in case of water-electrolyte balance disturbances.
Composition: Oxaliplatin 100mg Indication: - Oxaliplatin in combination with 5 fluorouracil is indicated for the adjuvant treatment of stage Ill colon cancer after complete resection of the primary tumor. - Treatment of metastatic rectal colon cancer.
Composition: Oxaliplatin 50mg Indication: Adjuvant treatment of stage III colon cancer (Duke stage C) after complete resection of the primary tumor. Treatment of metastatic colorectal cancer.
